Cargando…
Analysis of new drug registration and review in China in 2021
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279709/ https://www.ncbi.nlm.nih.gov/pubmed/35847501 http://dx.doi.org/10.1016/j.apsb.2022.02.018 |
| _version_ | 1784746459655045120 |
|---|---|
| author | Hu, Hongxi Lu, Xiaotong Xu, Huiyan Zhou, Liyun |
| author_facet | Hu, Hongxi Lu, Xiaotong Xu, Huiyan Zhou, Liyun |
| author_sort | Hu, Hongxi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9279709 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92797092022-07-15 Analysis of new drug registration and review in China in 2021 Hu, Hongxi Lu, Xiaotong Xu, Huiyan Zhou, Liyun Acta Pharm Sin B News Elsevier 2022-04 2022-02-24 /pmc/articles/PMC9279709/ /pubmed/35847501 http://dx.doi.org/10.1016/j.apsb.2022.02.018 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | News Hu, Hongxi Lu, Xiaotong Xu, Huiyan Zhou, Liyun Analysis of new drug registration and review in China in 2021 |
| title | Analysis of new drug registration and review in China in 2021 |
| title_full | Analysis of new drug registration and review in China in 2021 |
| title_fullStr | Analysis of new drug registration and review in China in 2021 |
| title_full_unstemmed | Analysis of new drug registration and review in China in 2021 |
| title_short | Analysis of new drug registration and review in China in 2021 |
| title_sort | analysis of new drug registration and review in china in 2021 |
| topic | News |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279709/ https://www.ncbi.nlm.nih.gov/pubmed/35847501 http://dx.doi.org/10.1016/j.apsb.2022.02.018 |
| work_keys_str_mv | AT huhongxi analysisofnewdrugregistrationandreviewinchinain2021 AT luxiaotong analysisofnewdrugregistrationandreviewinchinain2021 AT xuhuiyan analysisofnewdrugregistrationandreviewinchinain2021 AT zhouliyun analysisofnewdrugregistrationandreviewinchinain2021 |